ERD

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

01-02-2017

-

31-01-2019

Show more information

Organisation MERCK SHARP & DOHME CORP

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation MERCK SHARP & DOHME CORP

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

01-10-2016

-

31-05-2022

Show more information

Organisation MERCK SHARP & DOHME CORP

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation MERCK SHARP & DOHME CORP

PharmaLedger | PharmaLedger

01-01-2020

-

31-12-2022

Show more information

Organisation MERCK SHARP & DOHME CORP

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

01-02-2019

-

31-01-2025

Show more information

Organisation MERCK SHARP & DOHME CORP

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation MERCK SHARP & DOHME CORP

VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation

01-01-2019

-

31-12-2024

Show more information

Organisation MERCK SHARP & DOHME CORP

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

01-01-2017

-

31-12-2024

Show more information

Organisation MERCK SHARP & DOHME CORP

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

01-12-2019

-

30-11-2025

Show more information

Organisation MERCK SHARP & DOHME CORP

NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery

01-03-2019

-

30-09-2022

Show more information

Organisation MERCK SHARP & DOHME CORP

VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068

01-04-2016

-

31-03-2023

Show more information

Organisation MERCK SHARP & DOHME CORP

Projects overview

Selected filters:

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

PharmaLedger | PharmaLedger

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery

VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068